Characterisation of the triclosan efflux pump TriABC and its regulator TriR in Agrobacterium tumefaciens C58. Nontaleerak B, Tasnawijitwong N, Eurtivong C, Sirikanchana K, Satayavivad J, Sukchawalit R, Mongkolsuk S. Microbiol Res. 2022 Oct;263:127112. doi: 10.1016/j.micres.2022.127112. Epub 2022 Jul 4. PMID: 35810656

01 Oct 2022
0
0

Characterisation of the triclosan efflux pump TriABC and its regulator TriR in Agrobacterium tumefaciens C58.
Nontaleerak B, Tasnawijitwong N, Eurtivong C, Sirikanchana K, Satayavivad J, Sukchawalit R, Mongkolsuk S.
Microbiol Res. 2022 Oct;263:127112. doi: 10.1016/j.micres.2022.127112. Epub 2022 Jul 4.
PMID: 35810656

Tags

Share this

Related Posts

Aberrant RL2 O-GlcNAc antibody reactivity against serum-IgA1 of patients with colorectal cancer. Verathamjamras C, Sriwitool TE, Netsirisawan P, Chaiyawat P, Chokchaichamnankit D, Prasongsook N, Srisomsap C, Svasti J, Champattanachai V*. Glycoconj J. 2021 Feb;38(1):55-65.
01 Feb 2021
0

Aberrant RL2 O-GlcNAc antibody reactivity against serum-IgA1 of patients with colorectal cancer. Verathamjamras C, Sriwitool TE, Netsirisawan P, Chaiyawat P, Chokchaichamnankit D, Prasongsook N, Srisomsap C, Svasti J, Champattanachai V*. Glycoconj J. 2021 Feb;38(1):55-65.

Aberrant RL2 O-GlcNAc antibody reactivity against serum-IgA1 of patients with colorectal cancer. Verathamjamras C, Sriwitool TE, Netsirisawan P, Chaiyawat P, Chokchaichamnankit D, Prasongsook N, Srisomsap C, Svasti J, Champattanachai V*. Glycoconj J. 2021 Feb;38(1):55-65.
View More

Recent Posts